| Literature DB >> 28598567 |
Ryoji Ito1, Takeshi Takahashi1, Mamoru Ito1.
Abstract
Humanized mice are superior to rodents for preclinical evaluation of the efficacy and safety of drug candidates using human cells or tissues. During the past decade, humanized mouse technology has been greatly advanced by the establishment of novel platforms of genetically modified immunodeficient mice. Several human diseases can be recapitulated using humanized mice due to the improved engraftment and differentiation capacity of human cells or tissues. In this review, we discuss current advanced humanized mouse models that recapitulate human diseases including cancer, allergy, and graft-versus-host disease.Entities:
Keywords: GVHD; allergy; cancer; human disease; humanized mice
Mesh:
Year: 2017 PMID: 28598567 DOI: 10.1002/jcp.26045
Source DB: PubMed Journal: J Cell Physiol ISSN: 0021-9541 Impact factor: 6.384